Insulin Resistance, Impaired Early Insulin Response, and Insulin Propeptides as Predictors of the Development of Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—Defects in insulin secretion and insulin action are the major abnormalities in the development of type 2 diabetes. In middle-aged subjects, elevated plasma proinsulin has been found to predict type 2 diabetes. Therefore, our aim was to study the longitudinal relationships between baseline determinations of insulin sensitivity index (Si) assessed by euglycemic insulin clamp, the early insulin response (EIR) at an oral glucose tolerance test (OGTT), fasting intact proinsulin, 32–33 split proinsulin and specific insulin, and the development of type 2 diabetes in a population-based cohort of 70-year-old nondiabetic men (n = 667) with 7-year follow-up. RESEARCH DESIGN AND METHODS—A euglycemic insulin clamp study and a 75-g OGTT were performed at baseline, and fasting peptide concentrations were measured using specific two-site immunometric assays. Results from logistic regression models are presented as odds ratios (ORs) with 95% CIs for a 1-SD increase in the predictor variable. RESULTS—In separate multivariate analyses adjusted for EIR (OR 0.72, 95% CI 0.59–0.89) and Si (0.68, 0.58–0.88), 32–33 split proinsulin (1.49, 1.18–1.88) or intact proinsulin (1.30, 1.04–1.63) were significantly associated with the development of type 2 diabetes, whereas specific insulin (1.24, 0.91–1.66) was not. The significant associations between 32–33 split or intact proinsulin and the development of type 2 diabetes were unaltered after adjustment for BMI and glucose tolerance. CONCLUSIONS—Insulin propeptides predicted type 2 diabetes over a 7-year period in elderly men, independent of the EIR and Si.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
Lillioja, S., Mott, D. M., Spraul, M., Ferraro, R., Foley, J. E., Ravussin, E., Knowler, W. C., Bennett, P. H., & Bogardus, C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292703 · Cited by 1,508 · cited 1×
“Impaired insulin secretion and impaired insulin action are the major defects underlying the development of type 2 diabetes (1,2).”
BackgroundPhillips, D. I. W., Clark, P. M., Hales, C. N., & Osmond, C. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00273.x · Cited by 631 · cited 1×
“EIR was defined as the ratio of the 30-min increment in insulin concentration to the 30-min increment in glucose concentration after oral glucose loading (22).”
MethodSelf-citationThe natural history of impaired glucose tolerance in the Pima Indians
Saad, M. F., Knowler, W. C., Pettitt, D. J., Nelson, R. G., Mott, D. M., & Bennett, P. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812083192302 · Cited by 413
Kahn, S. E., & Halban, P. A. (1997) · Diabetes · doi:10.2337/diabetes.46.11.1725 · Cited by 221
Kahn, S. E., & Halban, P. A. (1997) · Diabetes · doi:10.2337/diab.46.11.1725 · Cited by 221
Yoshioka, N., Kuzuya, T., Matsuda, A., Taniguchi, M., & Iwamoto, Y. (1988) · Diabetologia · doi:10.1007/bf02341503 · Cited by 175 · cited 1×
“Proinsulin concentrations may also be augmented by an increased demand placed on -cells by hyperglycemia (30,31), i.”
BackgroundProinsulin as a marker for the development of NIDDM in Japanese-American men
Kahn, S. E., Leonetti, D. L., Prigeon, R. L., Boyko, E. J., Bergstrom, R. W., & Fujimoto, W. Y. (1995) · Diabetes · doi:10.2337/diabetes.44.2.173 · Cited by 138
Mykkanen, L., Haffner, S. M., Hales, C. N., Ronnemaa, T., & Laakso, M. (1997) · Diabetes · doi:10.2337/diabetes.46.12.1990 · Cited by 92
Self-citation
Cited by
Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes
Zethelius, B., Berglund, L., Sundström, J., Ingelsson, E., Basu, S., Larsson, A., Venge, P., & Ärnlöv, J. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707064 · Cited by 889
Self-citationInsulin Resistance and Risk of Congestive Heart Failure
Ingelsson, E., Sundström, J., Ärnlöv, J., Zethelius, B., & Lind, L. (2005) · JAMA · doi:10.1001/jama.294.3.334 · Cited by 573
Self-citationAntidiabetic effects of fermented soybean products on type 2 diabetes
Kwon, D. Y., Daily, J. W., Kim, H. J., & Park, S. (2010) · Nutrition Research · doi:10.1016/j.nutres.2009.11.004 · Cited by 368
Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia
Richter, B., Hemmingsen, B., Metzendorf, M.-I., & Takwoingi, Y. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012661.pub2 · Cited by 283
Zethelius, B., Johnston, N., & Venge, P. (2006) · Circulation · doi:10.1161/circulationaha.105.570762 · Cited by 280
Self-citation
Metadata
- Authors
- Zethelius, B., Hales, C. N., Lithell, H. O., & Berne, C.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2004-06-01
- Volume
- 27
- Issue
- 6
- Pages
- 1433-1438
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W1978195880
- Cited by
- 60
- References
- 9
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Insulin Resistance, Impaired Early Insulin Response, and Insulin Propeptides as Predictors of the Development of Type 2 Diabetes. https://app.cochat.ai/papers/10.2337/diacare.27.6.1433
- The paper
- Zethelius, B., Hales, C. N., Lithell, H. O., & Berne, C. (2004). Insulin Resistance, Impaired Early Insulin Response, and Insulin Propeptides as Predictors of the Development of Type 2 Diabetes. Diabetes Care. https://doi.org/10.2337/diacare.27.6.1433
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.